Origene Technologies
US-based OriGene provides comprehensive gene-based research solutions including cDNA clones, antibodies, proteins, and more.
Founded
1996US-based OriGene provides comprehensive gene-based research solutions including cDNA clones, antibodies, proteins, and more.
Founded in Rockville, United States, OriGene Technologies is dedicated to advancing gene-based research by providing comprehensive solutions such as over 37,000 human full-length ORF cDNA clones, 50,000 primary antibodies, 10,000 human proteins, and various other research reagents. The company's core mission is to support scientific discoveries and innovations in fields like oncology, neuroscience, immunology, and signal transduction through high-quality products and services.
OriGene has garnered attention for its extensive catalog and commitment to quality, attracting notable researchers and institutions globally. The company has achieved significant milestones in the development of custom antibody solutions and CRISPR tools, enhancing the capabilities of laboratories worldwide. OriGene's impact is evident in its contribution to numerous scientific publications and advancements in medical research, solidifying its reputation as a pivotal player in the biotechnology industry.
Companies similar to Origene Technologies include ABclonal, Cayman Chemical Company, Origen Therapeutics and Zymo Research.
Origene Technologies was founded in 1996.
Origene Technologies' headquarters is located in Rockville, MD, US.
Origene Technologies' most recent funding round was for $17.1M (USD) in June 2015.
As of Jun 9, 2015, Origene Technologies has disclosed funding of $69.4M (USD). Undisclosed round amounts are excluded.
Origene Technologies has 750 employees as of Feb 5, 2024.
Zymo Research
zymoresearch.com
